A Novel Link Between SUMO Modification and Cancer Metastasis
concomitantly recruited on the promoter along with the Tip60coactivator. Given that pontin and reptin are highly homologousand occasionally work antagonistically,16,17it would be interestingto also elucidate the role of pontin in cancer metastasis. The bindingof Tip60 coactivator complex to the KAI1promoter appears to bemutually exclusive with the actively repressing β-catenin-reptincomplex.8An altered balance of these opposing complexes controlsthe KAI1gene expression and its metastatic potential.
These findings offer a paradigm for investigating the mechanismsinvolved in the downregulation of metastasis suppressor genes in theprogression of metastatic behavior in cancer. KAI1is the first genewhose transcriptional regulatory mechanism has been studied indetail. Genome-wide approaches to search for potential metastasissuppressor genes will help elucidate the molecular mechanismsinvolved in the inhibition of metastasis. Further, the investigation ofupstream signals, which increase or decrease the expression of metasta-sis suppressor genes, will enable the clarification of several unansweredquestions. Studying the transcriptional regulatory mechanism ofother potential metastasis suppressors reported to date will alsounravel the presence of common regulatory mechanisms amongthem and open numerous avenues of investigation. In addition, theinvestigation of cross talk between many signaling pathways thatregulate the metastases would be helpful. A type of balancing mod-ule may exist between the progression and suppression of metastasis.
SUMO WRESTLES ITS WAY TO CANCER METASTASIS
upstream signals that trigger SUMO conjugation and deconjugation,it is necessary to determine the mechanisms involving certain proteins.Information regarding the preference for conjugation or deconjuga-tion in certain signal transduction pathways as well as in the cellularcontext will provide an insight on the biological function of theprotein. Ubc9 has been identified as the only E2 SUMO conjugatingenzyme, whereas the deSUMOylation process has been ascribed to anumber of deSUMOyating enzymes. Therefore, it is tempting tospeculate that the change in the expression of the deSUMOylatingenzyme might possibly affect SUMOylation of proteins includingreptin.9
SUMO CONJUGATION AND DECONJUGATION
SUMO (small ubiquitin-like modifier) is a small molecule;however, it appears to have as many regulatory roles in cells as ubiq-uitin.24-30Although ubiquitin was discovered more than 25 yearsago, SUMO was discovered less than 10 years ago. However, this lateentrant is becoming an important molecule in cell biology and cancerbiology. Posttranslational modification of proteins by SUMO is akey regulatory cellular mechanism that is involved in several cellularprocesses, including transcriptional regulation and subcellular local-ization.31,32Since the addition of SUMO to transcription factorsand other cofactors tends to decrease the transcriptional activity, theresult is an overall decrease in target gene expression. The protein isalso required for protecting the genome during the separation of thechromosomes in mitosis and repairing damaged DNA.33-35It wouldbe challenging to determine the novel roles of SUMOylation in cells.The general pathways for ubiquitin and SUMO conjugationshare some common components.24-32The initial maturation stepof SUMO requires C-terminal processing, leading to the exposure ofa GG motif at its C-terminal end, allowing the conjugation processto occur. Following this step, heterodimeric E1 enzymes, SAE1/SAE2, catalyze the ATP-dependent activation step. While several E2enzymes play a role in ubiquitin-conjugation, thus far, Ubc9 hasbeen ascribed to function as a single E2 SUMO-conjugating enzyme.E3 SUMO ligases include PIAS and RanBP2. An additional signaturefor SUMOylation includes a consensus motif, ψKXE, where ψrepresents a large hydrophobic amino acids and X represents anyamino acid.
In addition to the SUMO conjugating enzymes, there aredeSUMOylating enzymes that have opposing roles.36-38SUMOconjugation and deconjugation is a dynamic process, and proteinsconjugated to SUMO are highly susceptible to deconjugation. Thisfunction has been attributed to several isopeptidases, exemplified bysentrin-specific protease (SENP1), SUMO-specific protease(SUSP1), and ubiquitin-like protease (Ulp).36-38To elucidate thedoc.guandang.net
With SUMOylation apparently involved in a variety of cellularprocesses, it is not surprising that it may have an important role indiseases as well. A number of oncogenes and tumor suppressorgenes, including PML, Mdm2, c-Myb, c-Jun, Rb and p53, undergoSUMOylation;39-46however, the functional significance ofSUMOylation of these molecules in cancer has not yet been exten-sively studied. SUMOylation has different functions in the regulationof oncogenes and tumor suppressor genes. PML is a nuclearphosphoprotein, and SUMOylation of PML is important for theformation of the nuclear body. Mdm2 is a RING finger protein withE3 ubiquitin ligase activity, and SUMOylation of Mdm2 has beenshown to increase its E3 activity towards p53 tumor suppressor.SUMO negatively regulates c-Jun activity and thus restricts itsoncogenic capacity. SUMOylation of c-Myb increases its stabilitybut negatively regulates the transactivation function of c-Myb.Increasing evidences support the notion that protein SUMOylationis important in the course of tumorigenesis and oncogenesis, andaltered in human cancer.47
Cancer metastasis is the process by which tumor cells spreadalmost uncontrollably from the primary tumor to form secondarytumors at a distant organ in the body.1,2Elucidating the mechanismby which this complex process is controlled at the molecular levelwill be tremendously helpful in developing new therapeuticapproaches for treating metastatic cancer. Our recent study attemptsto link SUMO modification and cancer metastasis.9To identify thesignaling factor that confers repressive function on the reptin chro-matin remodeling complex, resulting in the repression of KAI1metastasis suppressor gene expression, the reptin-containing complexwas biochemically purified. Identification of deSUMOylatingenzymes in the reptin-containing complex prompted us to study theroles of SUMOylation of reptin in the regulation of KAI1. ThedeSUMOylating enzyme SENP1 reverses the SUMOylation of reptinthat underlies the repressive function. Further, deSUMOylationofreptin alters the repressive function of reptin and its association withHDAC1. The SUMOylation status of reptin modulates the invasiveactivity of cancer cells with metastatic potential.
The problem encountered in studying SUMO modification ofcertain proteins is the relatively small portion of protein that under-goes SUMOylation. Since it is a dynamic process, SUMOylationprocess cannot be separated from the deSUMOylation process. Toovercome the limitation of a relatively low percentage ofSUMOylation that has significant effects on many biologicalprocesses, N-or C-terminal fusion of SUMO to a target protein issometimes used. This cannot mimic the structure of the isopeptideSUMO chain in vivo; however, it can represent the constitutiveSUMOylation status to some extent. Because of the various functional
1493
Cell Cycle
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
热门文档